NO20055750L - Nye kjemiske forbindelser - Google Patents

Nye kjemiske forbindelser

Info

Publication number
NO20055750L
NO20055750L NO20055750A NO20055750A NO20055750L NO 20055750 L NO20055750 L NO 20055750L NO 20055750 A NO20055750 A NO 20055750A NO 20055750 A NO20055750 A NO 20055750A NO 20055750 L NO20055750 L NO 20055750L
Authority
NO
Norway
Prior art keywords
chemical compounds
new chemical
compounds
preparing
useful
Prior art date
Application number
NO20055750A
Other languages
English (en)
Norwegian (no)
Other versions
NO20055750D0 (no
Inventor
Kristjan Gudmundsson
Sharon Davis Boggs
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20055750D0 publication Critical patent/NO20055750D0/no
Publication of NO20055750L publication Critical patent/NO20055750L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/82Carbazoles; Hydrogenated carbazoles
    • C07D209/88Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
NO20055750A 2003-06-12 2005-12-05 Nye kjemiske forbindelser NO20055750L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47797203P 2003-06-12 2003-06-12
US49778703P 2003-08-26 2003-08-26
PCT/US2004/018180 WO2005005386A1 (en) 2003-06-12 2004-06-07 Tetrahydrocarbazole derivatives and their pharmaceutical use

Publications (2)

Publication Number Publication Date
NO20055750D0 NO20055750D0 (no) 2005-12-05
NO20055750L true NO20055750L (no) 2006-01-06

Family

ID=34068099

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055750A NO20055750L (no) 2003-06-12 2005-12-05 Nye kjemiske forbindelser

Country Status (15)

Country Link
US (1) US7419997B2 (pt)
EP (1) EP1646610B1 (pt)
JP (1) JP2007500750A (pt)
KR (1) KR20060017544A (pt)
AU (1) AU2004256052A1 (pt)
BR (1) BRPI0411245A (pt)
CA (1) CA2528336A1 (pt)
CO (1) CO5660264A2 (pt)
DE (1) DE602004022169D1 (pt)
ES (1) ES2327416T3 (pt)
IL (1) IL172087A0 (pt)
MA (1) MA27879A1 (pt)
NO (1) NO20055750L (pt)
RU (1) RU2005138126A (pt)
WO (1) WO2005005386A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007509057A (ja) * 2003-10-15 2007-04-12 カイロン コーポレイション ウイルス阻害のための組成物および方法
US8076352B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Administration of carboline derivatives useful in the treatment of cancer and other diseases
US8076353B2 (en) 2004-03-15 2011-12-13 Ptc Therapeutics, Inc. Inhibition of VEGF translation
US7767689B2 (en) 2004-03-15 2010-08-03 Ptc Therapeutics, Inc. Carboline derivatives useful in the treatment of cancer
EP1737461B1 (en) 2004-03-15 2012-12-12 PTC Therapeutics, Inc. Carboline derivatives useful in the inhibition of angiogenesis
WO2006012310A2 (en) * 2004-06-25 2006-02-02 Genzyme Corporation Carbazole derivatives for treating polycystic kidney disease
US20090170906A1 (en) * 2004-11-22 2009-07-02 Kristjan Gudmundsson Hcv inhibitors
CA2588607A1 (en) * 2004-11-23 2006-06-01 Ptc Therapeutics, Inc. Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
WO2019005841A1 (en) * 2017-06-26 2019-01-03 Rutgers, The State University Of New Jersey THERAPEUTIC COMPOUNDS AND METHODS FOR TREATING INFECTION
US10882821B1 (en) 2017-09-26 2021-01-05 The Board Of Trustees Of The Leland Stanford Junior University Enantiomeric compound for the reduction of the deleterious activity of extended nucleotide repeat containing genes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9008108D0 (en) * 1990-04-10 1990-06-06 Bayer Ag Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
GB0015904D0 (en) * 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
DE10164564B4 (de) * 2001-12-14 2007-05-16 Zentaris Gmbh Tetrahydrocarbazolderivate als Liganden für G-Protein gekoppelte Rezeptoren (GPCR)

Also Published As

Publication number Publication date
US7419997B2 (en) 2008-09-02
EP1646610A1 (en) 2006-04-19
WO2005005386A1 (en) 2005-01-20
US20060148857A1 (en) 2006-07-06
NO20055750D0 (no) 2005-12-05
JP2007500750A (ja) 2007-01-18
CA2528336A1 (en) 2005-01-20
MA27879A1 (fr) 2006-05-02
CO5660264A2 (es) 2006-07-31
KR20060017544A (ko) 2006-02-23
DE602004022169D1 (de) 2009-09-03
ES2327416T3 (es) 2009-10-29
AU2004256052A1 (en) 2005-01-20
RU2005138126A (ru) 2006-07-27
IL172087A0 (en) 2009-02-11
BRPI0411245A (pt) 2006-07-18
EP1646610B1 (en) 2009-07-22

Similar Documents

Publication Publication Date Title
NO20055750L (no) Nye kjemiske forbindelser
NO20055741L (no) Nye kjemiske forbindelser
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
NO20063479L (no) Fosfonater, monofosfonamidater og bis-fosfonamidater for behandling av virussykdommer
NO20082496L (no) Pyrazinderivater
ATE368031T1 (de) Neue gamma secretase inhibitoren
NO20054361L (no) Benzensylfonamidderivater, fremgangsmate for fremstilling og anvendelse derav for behandlig av smerte
NO20060230L (no) Nye aminobenzofenonforbindelser
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
WO2005013892A3 (en) Hydrolytically-resistant boron-containing therapeutics and methods of use
NO20055731L (no) Cannabinoide reseptorligander og deres anvendelse
ATE396174T1 (de) Hydroxyalkylaminderivate als beta-secretase- inhibitoren und deren verwendung zur behandlung der alzheimerschen krankheit oder ähnlicher krankheiten
NO20055977L (no) Nye benzimidazolderivater
NO20076638L (no) Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren
TW200726767A (en) Chemical compounds 2
NO20063576L (no) 1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
NO20060314L (no) Nicotinamid-derivater anvendbare som PDE4-inhibitorer
CY1109962T1 (el) Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4,5]δεκαν-2-ονης για τη θεραπεια παχυσαρκιας
SE0301368D0 (sv) Chemical compounds
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
NO20060718L (no) Substituerte tiofoner og deres anvendelse
NO20055205L (no) 4-(2-fcnylsulfanyl-fenyl)-1,2,3,6-tydropyridinderivater som serotoniniopptaksinhibitorer
DE602004031410D1 (de) Inden derivate als pharmazeutika
SE0300850D0 (sv) Chemical compounds
ATE417856T1 (de) Motilidverbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application